Treatment Relapsed Subcutaneous Panniculitis-like T-Cell Lymphoma together HPS by Cyclosporin A

Ren'an Chen; Li Liu; Yinmin Liang

doi:10.4081/hr.2010.e9

You are currently viewing a new version of our website. To view the old version click .

Hematology Reports is published by MDPI from Volume 14 Issue 1 (2022). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with PAGEPress.

Brief Report

30 November 2010

Treatment Relapsed Subcutaneous Panniculitis-like T-Cell Lymphoma together HPS by Cyclosporin A

and

Department of Haematology, Tang du Hospital, Fourth Military Medical University, Xi’an 710038, China

Author to whom correspondence should be addressed.

Hematol. Rep.2010, 2(1), e9;https://doi.org/10.4081/hr.2010.e9

Version Notes

Order Reprints

Abstract

A 25-year-old man was diagnosised subcutaneous panniculitis-like T-cell lymphoma (SPTCL) through biopsy of a nodule from the anterior chest. After the treatment with prednisone 90 mg 3 weeks and tapered off in 1 month, the disease released, but relapsed together with symptions of hemophagocytic syndrome eight months after the termination of prednisone. CHOEP recipe was given but with unsatisfactory result until cyclosporine was prescribed. Cyclosporine was removed 6 months later. There is no evidence of clinical relapse 1 year later. This case suggest that cyclosporine could be a selectable treatment even in relapsed SPTCL.

Keywords:

relapsed; subcutaneous panniculitislike T-cell lymphoma; cyclosporin A

Article Metrics

Citations

Article Access Statistics

Journal Statistics

Multiple requests from the same IP address are counted as one view.

Autonomic Dysfunction in Hodgkin and Non-Hodgkin Lymphoma. A Paraneoplastic Syndrome?

Dural MALT Lymphoma with Disseminated Disease